(BFW) FTSE 100 to Outperform, Called Up 106 Points at IG Index


FTSE 100 to Outperform, Called Up 106 Points at IG Index
2015-05-08 05:32:34.153 GMT


By James Ludden
(Bloomberg) -- FTSE 100 expected to post “fairly
sizeable” gain at open as Cameron’s Conservative Party
projected to remain in government, IG Index says.
* Latest BBC projection has Conservatives with 325 seats, one
short of absolute majority
* Banks, utilities, energy make up 45% of FTSE 100, sectors
that were regarded as under pressure from prospect of
Labour-led govt
* Before election, Conservative victory was regarded at Citi
as the only positive for utilities; Centrica, SSE most
exposed
* Focus may turn to EU referendum; Conservatives are committed
to holding an “in-out” vote by end-2017
* NOTE: HSBC said April 24 that one aspect of its review
of whether to move headquarters was U.K. membership of
EU
* City Index said FTSE 100 may open up 70pts if the exit
poll was correct; Jefferies also expects a positive
reaction
* City Index said FTSE 100 may open up 70pts if the exit
poll was correct; Jefferies also expects a positive
reaction</li></ul>


For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>

To contact the reporter on this story:
James Ludden in London at +44-20-3525-2645 or
jludden@bloomberg.net
To contact the editor responsible for this story:
Andrew Rummer at +44-20-3525-3722 or
arummer@bloomberg.net

NYT : Uber Joins the Bidding for Here, Nokia’s Digital Mapping Service

Uber Joins the Bidding for Here, Nokia’s Digital Mapping Service http://nyti.ms/1H2XJsQ


Uber is best known for allowing people to book a taxi through its smartphone application. But the fast-growing company has far broader ambitions.

More and more, Uber is positioning itself as a logistics company. The goal is to deliver people and things within cities as quickly as possible — relying heavily on Google’s Maps in the process.

That dependency may soon change.

Uber has submitted a bid for Here, the main competitor to Google Maps, for as much as $3 billion, according to three people with knowledge of the offer, who spoke on the condition of anonymity. Here is owned by Nokia, the Finnish telecom giant, which announced last month that it was considering selling the business.

Continue reading the main story
RELATED COVERAGE

Auto rickshaws in New Delhi. The company is trying to improve the image of the vehicles and their drivers.New Delhi Journal: Uber Adds a Low-Tech Twist to Its Modern Business Model in IndiaAPRIL 20, 2015
An Uber app in use in Berlin. A judge on Wednesday found Uber to be in violation of Germany’s public transportation act.An Uber Service Is Banned in Germany AgainMARCH 18, 2015
Nokia Provides Free Mapping Services App for Apple UsersMARCH 12, 2015
Uber Heads in New Mapping Direction With deCarta AcquisitionMARCH 4, 2015
The bid is competing with one in the works from a consortium of German automakers, including BMW, Audi and Mercedes-Benz, according to two of those people. The automakers are teaming up with the Chinese search engine Baidu on the offer, the people said. A separate bid from an undisclosed private equity firm has also been submitted, and Nokia is expected to announce the sale of its mapping unit by the end of May.

Photo

Mapping the streets of Warwick, Britain. Nokia’s mapping business holds more than an 80 percent global market share for built-in car navigation systems, and spends hundreds of millions each year to update its maps from New York to New Delhi. Credit Rob Stothard for The New York Times
Negotiations over the sale of Nokia’s mapping business are continuing and the talks still may not lead to a deal, the people cautioned. Representatives for Uber, the German automakers and Nokia declined to comment on the deal rumors.

The multibillion-dollar battle to buy Here highlights the growing importance of digital mapping services as companies connect their products to the Internet. Other tech giants, including Facebook and Microsoft, have previously shown interest in acquiring Nokia’s mapping unit.

The world’s automakers and tech giants like Google have unveiled a series of driverless car projects that rely heavily on up-to-date road data. Companies like Amazon and FedEx use mapping information to run their global logistics operations. And tech start-ups, including Uber and Airbnb, the vacation-rental website, have incorporated digital maps into the heart of their businesses.

While Google Maps has an estimated one billion mobile users, or about 10 times the amount of Here’s smartphone users, Nokia’s division dominates in automobile mapping — a field in which both Google and Apple, which has struggled with its own mapping service, have earmarked for growth.

Nokia’s mapping business holds more than an 80 percent global market share for built-in car navigation systems, and spends hundreds of millions of dollars each year to update its maps that span from New York to New Delhi. Here, which is based in Berlin, employs about 6,000 people worldwide to maintain Nokia’s digital maps and connected-car services with almost three million daily adjustments. The unit reported yearly revenue of $1.1 billion, or less than 8 percent of Nokia’s total sales in 2014, according company records.

“It’s extraordinarily difficult to get this type of mapping data,” said Jamie Moss, an analyst at the technology research company Ovum in London. “Other than Google, Here is one of the few companies that can offer this data right now.”


The mapping tool, they say, could help with services like Uber Pool, the company’s ride-sharing initiative, which uses geospatial mapping data to pair riders with drivers. To carry out such matches speedily, the company needs significant engineering power and a rich trove of mapping data, according to people with knowledge of the project.

In addition to Google’s Maps, Uber relies on data from Apple and other companies’ mapping initiatives, as well as its own online information.

Uber, whose backers include Google’s venture capital arm, has taken steps in recent months to hedge against its heavy reliance on the search giant. This year, for example, the company unveiled the Uber Advanced Technologies Center that, in partnership with Carnegie Mellon University, is working on mapping and autonomous vehicle technology.

And in March, Uber acquired deCarta, an almost decade-old mapping software company based in San Jose, Calif., to bolster its mapping efforts. The company also has hired a number of mapping software engineers in recent months, according to two people familiar with Uber’s hiring efforts.

The company’s plans, however, may still be outflanked by the German automakers, which also view Nokia’s mapping business as central to their future.

Mercedes and other automakers already are testing so-called autonomous vehicles that rely on Here’s technology to guide cars around city streets with limited intervention from drivers. They are reluctant to become overly dependent on Google’s Maps, which offers similar services, particularly because Google is working on autonomous vehicles of its own.

As part of its bid, the German consortium wants to give others access to Nokia’s mapping service, under a licensing agreement, so that the business can maintain its global reach and remain the primary competitor to Google Maps, according to a person with knowledge of the matter.

“Mapping data is an important long-term asset for the auto industry,” said Jeremy Carlson, an analyst at IHS Automotive, in Los Angeles. “It makes sense that they would want to protect it.”

(BFW) SALT Day 2 Wrap: Bass Has Perrigo Position, Chanos Short Shell


SALT Day 2 Wrap: Bass Has Perrigo Position, Chanos Short Shell
2015-05-08 00:54:07.413 GMT


By Joshua Fineman, Kelly Bit and Simone Foxman
(Bloomberg) -- Below is recap of long, short, macro,
credit ideas given at Day 2 of the SkyBridge Alternatives
Conference (SALT) in Las Vegas. Link to Day 1 WRAP

* Hayman’s Kyle Bass: Says He’s Long Perrigo; Sees Potential
for Abbott to Make Bid for Perrigo; Doesn’t Think Mylan Will
be Successful with Perrigo Bid; Sees Oil at $60-$65 by Year-
End; Bass Says Front End Oil Curve Risks ‘Amaranth’ Movement
Link to Bloomberg story

* Kynikos’s Jim Chanos: Says He’s Short Shell, Chevron; Says
BG Plan is a “bet the co.” Deal for Shell; Says BG’s
financials don’t look good; Still Expects BG Deal to Go
Through
Link to Bloomberg story

* T. Boone Pickens: Says Oil Production Will Decline in 30-60
Days

* Halcyon’s James McGinnis: Short Ensco, Noble, Transocean;
has long position in SolarCity
Link to Bloomberg story

* Axonic’s Clayton DeGiacinto Sees 20% 2005-07 CMBS Loan
Defaults

* Bridgewater’s David McCormick: Sees Oil Below $75 at Year-
End

* Apex’s Gil Simon: Likes Netflix, Sees Shrs Topping $2,000
Link to Bloomberg story

* Omega’s Leon Cooperman: Reiterates longs Dow, Citi, Google,
Aercap, Actavis, GM, Priceline, Gulf Coast Ultra
Link to Bloomberg story

* Passport’s John Burbank: Recommends Saudi Arabia’s NCB AB
long; Passport High on China Stocks as Fortress Sees Bull
Market

* Hunter Peak’s Michael Karsch: Recommends Portugal’s NOS;
Sees 100% upside to EU12.94 in 2018

* Balyasny’s Christian Zann: Likes Tetra Technologies, Trican
Well Service

* Latigo’s David Ford: Recommends IHeartMedia Long




For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>

To contact the reporter on this story:
Joshua Fineman in New York at +1-212-617-8953 or
jfineman@bloomberg.net
To contact the editor responsible for this story:
Arie Shapira at +1-212-617-1488 or
ashapira3@bloomberg.net

>>> Asian Update

Asian Mid-session Update: GBP spikes as Labour, Lib Dems flail in UK elections; Soft China trade components lift expectations for more easing


***Economic Data***
- (CN) CHINA APR TRADE BALANCE: $34.1B V $39.6BE
- (HK) Hong Kong Apr Foreign Reserves: $343.2B v $332.2B prior

***Index Snapshot (as of 02:30 GMT)***
- Nikkei225 +0.3%, S&P/ASX +0.7%, Kospi flat, Shanghai Composite +1.4%, Hang Seng +0.9%, Jun S&P500 +0.1% at 2,086

***Commodities/Fixed Income***
- Jun gold +0.1% at $1,183/oz, Jun crude oil -0.1% at $58.86/brl, May copper flat at $2.93/lb
- GLD: SPDR Gold Trust ETF daily holdings fall 2.7 tonnes to 739.1 tonnes
- (AU) Australia MoF (AOFM) sells A$1.5B in 1.75% 2020 Bonds; avg yield: 2.4114%; bid-to-cover: 2.32x
- JGB: (JP) Japan MoF sells ¥500B in 0.1% 10-year CPI-linked Bonds; Bid-to-cover ratio: 2.65x v 2.97x prior
- (US) Weekly Fed Balance Sheet Total Assets for week ending May 6th: $4.47T v $4.53T prior; Reserve Bank Credit: $4.43T v $4.44T prior; M1: -$4.7B v -$5.4B prior; M2: -$27.4B v -$1.7B prior; M1 y/y change: 8.9% v 9.1% w/w; M2 y/y change: 6.2% v 6.2% w/w

***Market Focal Points/FX***
- The trading sessions leading into the US non-farm payrolls are known for their subdued volatility, however this was hardly the case in today's Asian hours. In FX space, GBP saw particularly outsized gains on solid performance by ruling Conservatives and disappointing polls for opposition Labour and coalition member Liberal Democrats. Just after 4am GMT, Conservative Party picked up 14 seats and lost 5, while Labour lost 43 against +12 gained and LD lost 22 seats with none gained. Pro-independence Scottish National Party (SNP) results were especially impressive, picking up 46 seats. Note that 326 seats are needed for a majority, and Conservatives will still likely need to find a governing partner. GBP/USD spiked up some 150pips on the initial exit polls in early trade and added to those gains throughout the session, testing $1.55 level late in the session - a 2-month high. EUR/GBP collapsed 150pips as well to fall below £0.7240 - a 1-week low.

- Shanghai and Hong Kong led regional indices to the upside, with most pronounced gains coming after disappointing China trade data that lifted expectations for additional PBoC policy easing. Trade surplus was shy of expectations, exports fell for 2nd straight month by -6.2% v +1.6% expected, and imports fell for the 6th straight month by over 16% - much worse than 12% decline forecast. Shipments to US were up 3%, but exports to EU and Japan were down double digits. China press reports that Shenzhen-Hong Kong stock connect was approved was also notable for the H-shares which have previously attracted mainland inflows on cheaper valuations.

- Trading in Australia was also volatile, as AUD/USD fell as much as 50pips below $0.7870 on soft China trade numbers. Earlier, RBA quarterly policy statement lowered expectations for both GDP and inflation and warned that GDP would remain below trend for longer than anticipated. For 2015, GDP target was revised from 2.25-3.25% to 2.5% and for 2016 it was cut from 3.0-4.0% to 2.75-3.75%. 2015 CPI targets were little changed, but those of 2016 and 2017 H1 were all lowered by 0.25%. In Australia corporates, Macquarie posted strong FY results, beating net profit forecasts on nearly 300bps rise in ROE and raising its final dividend by 27%.

- Bank of Japan meeting minutes from Apr 7th offered little new, particularly in the wake of the more recent Apr 30th decision that saw BOJ push back its expectations of achieving 2% inflation target. Minutes did show some members showing concern that annual CPI could turn slightly negative if energy prices remain pressured. USD/JPY pair rose about 30pips, but failed to retest the key ¥120 handle.

***Equities***
US equities / ADRs:
- OUTR: Reports Q1 $2.23 v $1.67e, R$608.6M v $594Me; +5.6% afterhours
- MOH: Reports Q1 $0.71 v $0.50e, R$3.2B v $3.21Be; +3.9% afterhours
- NUAN: Reports Q2 $0.30 v $0.24e, R$475M v $482Me; Adds $500M to buyback plan (10% of market cap), +3.0% afterhours
- CBS: Reports Q1 $0.78 v $0.75e, R$3.50B v $3.50Be; +1.0% afterhours
- CERN: Reports Q1 $0.32 v $0.45e, R$996M v $1.09Be; -0.1% afterhours
- NVDA: Reports Q1 $0.33 v $0.26e, R$1.15B v $1.16Be; Raises dividend 15% to $0.0975; -2.0% afterhours
- MNST: Reports Q1 $0.62 (adj) v $0.68e, R$627M (adj) v $610Me; Planning for Long-Term Strategic Alignment with The Coca-Cola Company; -4.5% afterhours
- SFM: Reports Q1 $0.25 v $0.27e, R$857.5M v $870Me; -9.0% afterhours

Notable movers by sector:
- Consumer discretionary: Unicharm 8113.JP +1.3% (Q1 results); FAW Car CO 000800.CN -7.3% (YTD production and sales)
- Financials: Macquarie Group MQG.AU +4.9% (FY14/15 results); Suncorp Group SUN.AU +0.3% (Q3 results); Haitong Securities 6837.HK +2.7% (April results); CITIC Securities 6030.HK +4.1% (April results); Hutchison Whampoa 13.HK +1.9% (to sell stake in 3UK and O2UK); GF Securities Co 000776.CN +1.0% (April results)
- Industrials: Geely Automobile 175.HK +0.5% (April results)
- Technology: Nintendo Co 7974.JP +7.7% (FY14/15 results)

(BFW) Monsanto Said to Make Initial $45b Offer for Syngenta


BN 05/08 02:17 Monsanto Said to Make Initial $45b Offer for Syngenta
BFW 05/08 02:16 *SYNGENTA SAID TO REJECT MONSANTO'S OFFER OF ABOUT CHF450/SHARE
BFW 05/08 02:16 *MONSANTO SAID TO MAKE INITIAL $45B OFFER FOR SYNGENTA

Monsanto Said to Make Initial $45b Offer for Syngenta
2015-05-08 02:20:25.440 GMT


By Matthew Campbell and Ed Hammond
(Bloomberg) -- Monsanto made an initial offer for Syngenta
valuing its Swiss rival at about $45b, people with knowledge of
matter say.
* Monsanto offered about 450 Swiss francs per share; 35%
premium to Syngenta’s last close
* Syngenta rejected offer; though left it open for Monsanto to
make another offer or start talks
Link
Link to Company News:{MON US <Equity> CN <GO>}
Link to Company News:{SYNN VX <Equity> CN <GO>}

For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}

To contact the reporter on this story:
Matthew Campbell in London at +44-20-3525-8684 or
mcampbell39@bloomberg.net

To contact the editor responsible for this story:
Peter J. Brennan at +1-323-782-4233 or
pbrennan3@bloomberg.net

>>> US After Hours Summary: SSNI +22.6%, NPTN +21.7%, SEDG +15.4%, AMD

After Hours Summary: SSNI +22.6%, NPTN +21.7%, SEDG +15.4%, AMDA -31%, KEYW -21.5%, PLNR -15.2% following earnings/guidance

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings: SSNI +22.6%, NPTN +21.7%, SEDG +15.4%, IMPV +12.4%, PLPM +9.7%, WPRT +8.7%, HNSN +8.3%, DATA +8.1%, STMP +7.1%, RBA +6.3%, BKD +5.3%, SAAS +5.3%, CALA +5%, OUTR +5%, ENOC +4.5%, MOH +3.9%, RLYP +3.5%, GSAT +3.5%, RYI +3.3%, ACET +3%, NUAN +2.6%, CYBR +2.5%, SWIR +2.2%, CPXX +2%, PGH +2%, ACAD +1.9%, AIRM +1.9%, XOMA +1.8%, ALSK +1.8%, FUEL +1.7%

Companies trading higher in after hours in reaction to news: NVGN +21.3% (move being attributed to press release regarding the presentation of positive pre-clinical date for TRXE-009 for the treatment of brain cancer), SCMP +6.1% (announced that the FDA has granted Fast Track Designation for Cobiprostone, for the prevention of oral mucositis), AMRN +5.1% (disclosed it filed a lawsuit against the FDA to permit the sharing of 'truthful and non-misleading information' with healthcare professionals in the
US that would be considered off-label), MCRL +2.2% (to be acquired by Microchip Technology (MCHP) for $14 per share), SWIR +2.2% (to acquire connectivity services provider Accel; co also reported earnings), NOK +1.3% (seeing reports that Uber has joined in bidding for co's maps unit; bidding up to $3 bln), BIIB +1.1% (announced Board authorization for a $5 bln share repurchase program, in addition to its existing 1.3 mln share authorization), SYT +0.8% (seeing reports that co may be acquired by Monsanto (MON))

After Hours Losers:

Companies trading lower in after hours in reaction to earnings: AMDA -31%, KEYW -21.5%, PLNR -15.2%, BIOS -15%, FLDM -14.8%, TWOU -14.2%, BEBE -12.3%, SFM -8.6%, DXPE -8.5%, AVNW -7.9%, AVID -7.4%, MDVN -6.3%, UBNT -5.9%, AL -5.5%, SPPI -4.9%, MNST -4.8%, PSIX -4.8%, JAZZ -3.7%, BBOX -3.4%, NOG -3.3%, GALE -2.2%, NVDA -2%, EGY -1.9%, UEPS -1.8%, WAIR -1.6%, FRPT -1.4%, MACK -1.3%, FATE -1.3%, ESPR -1.2%, MCHP -0.9%

Companies trading lower in after hours in reaction to news: LJPC
-6.6% (announced it will discontinue development of its polysaccharide-based galectin-3 inhibitors, GCS-100 and LJPC-1010),
CNCE -5.2% (co and Jazz Pharmaceuticals (JAZZ) reported results from their Phase 1 clinical study of JZP-386; studies do not support advancing into a later-stage clinical trial of JZP-386 at this time), CEMP -1.7% (filed mixed securities shelf offering), SMLP -0.3% (priced public offering of 6.5 mln common units at $30.75 per unit) 

(BFW) *SYNGENTA SAID TO HIRE GOLDMAN FOR POSSIBLE MONSANTO DEAL: RTRS



BFW 05/07 19:55 *SYNGENTA SAID TO HIRE GOLDMAN FOR POSSIBLE MONSANTO DEAL: RTRS

Syngenta Said to Hire Goldman for Possible Monsanto Deal: Rtrs
2015-05-07 19:58:44.246 GMT


By Beth Mellor
(Bloomberg) -- Monsanto hires Morgan Stanley to advise on
potential Syngenta deal, Reuters reports, citing people
familiar.
* BASF, Dow Chemical seen as potential suitors for all or
parts of Syngenta, Reuters says
* MON up as much as 2.3%; SYT up as much as 7%
* NOTE: May 1: Monsanto Is Said to Approach Syngenta Again
About a Takeover: Link

Link to Company News:{MON US <Equity> CN <GO>}
Link to Company News:{SYNN VX <Equity> CN <GO>}
Link to Company News:{BAS GR <Equity> CN <GO>}
Link to Company News:{DOW US <Equity> CN <GO>}

For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}

To contact the reporter on this story:
Beth Mellor in New York at +1-212-617-3078 or
bmellor@bloomberg.net

To contact the editor responsible for this story:
Arie Shapira at +1-212-617-1488 or
ashapira3@bloomberg.net

(BN) Abbott’s Mylan Billions Open Door for Bigger Purchases: Real M&A



Abbott’s Mylan Billions Open Door for Bigger Purchases: Real M&A
2015-05-07 21:55:27.873 GMT


(For a Real M&A column news alert: {SALT REALMNA <GO>}.)

By Brooke Sutherland and Michelle Fay Cortez
(Bloomberg) -- Mylan NV’s three-way deal drama is putting
the spotlight on a fourth player: Abbott Laboratories.
Abbott is the largest holder of Mylan after swapping its
established-markets drug business for Mylan stock in February.
Since then, Mylan shares have surged more than 20 percent as the
drugmaker pursues Perrigo Co. and fends off advances from Teva
Pharmaceutical Industries Ltd.
Mylan’s rise has added billions to the value of Abbott’s
stake, leaving it at about $5 billion even after Abbott sold
some of the shares, according to data compiled by Bloomberg.
That gives Chief Executive Officer Miles White a bigger bankroll
to spend on the acquisitions, big and small, that he’s looking
for.
Investors “might get a little noisier about what the next
steps are several quarters out if they don’t start to see how
that money is being spent,” Jeff Windau, a St. Louis-based
analyst at Edward Jones & Co., said by phone. “You’re going to
see potentially more questions to management.”
Since splitting with AbbVie Inc. in 2013, Abbott has shied
away from big purchases. Meantime, its former sister has pursued
two blockbuster deals valued at more than $70 billion combined.
Abbott instead has focused on rounding out its generic-drug
offerings in emerging markets and adding new technology for the
$69 billion company’s device and diagnostics businesses.
Abbott doesn’t need acquisitions to fuel growth in the same
way that AbbVie does as a drug developer facing the expiration
of its biggest product Humira, so Abbott may continue to steer
away from big takeovers, said Jeff Vancavage, a fund manager at
Abbott shareholder Eagle Asset Management Inc. Still, Abbott’s
growing resources mean investors are going to be looking for
more than $100 million deals.

Sweet Spot

A purchase of $2 billion to $4 billion may be in the sweet
spot, said George Strietmann of Bahl & Gaynor Investment Counsel
Inc. A takeover that ranked on the high end of that range would
be Abbott’s biggest yet since splitting with AbbVie.
“They certainly have room to do a fairly good-sized
acquisition,” Strietmann, a principal and fund manager at Bahl
& Gaynor, which oversees about $14 billion, including shares of
Abbott, said in a phone interview. “I would expect them to
continue doing more fine-tuning of their businesses.”

Deal Capacity

On an April 22 call with analysts, CEO White said “I
wouldn’t want you to think you’re only going to see ‘little’ out
of me” and he can’t rule out bigger additions. Abbott still
holds about 70 million of the 110 million shares it received
from Mylan, data compiled by Bloomberg show. Abbott has the
ability to do an acquisition of up to about $25 billion, said
Jonathan Palmer of Bloomberg Intelligence.
If White wanted to be bold, he could transform Abbott into
a cardiovascular powerhouse with an acquisition of St. Jude
Medical Inc., said Jeff Jonas, a fund manager at Gabelli. St.
Jude has a market value of $20 billion. Edwards Lifesciences
Corp., a $13 billion company, is another big acquisition target
that would build out Abbott’s cardiovascular business, said Igor
Golalic of Diamond Hill Capital Management.
“The one I dream about is for them to buy St. Jude,”
Jonas said. “There are a ton of synergies and you could make it
work.”
Both St. Jude and Edwards Lifesciences are probably too
pricey right now for Abbott, even if they would be ideal fits,
said Jonas and Golalic. Diamond Hill owns Abbott shares among
the $16 billion in assets that it oversees.
Scott Stoffel, a spokesman for Abbott Park, Illinois-based
Abbott, declined to comment. A representative for St. Paul,
Minnesota-based St. Jude also declined to comment, while a
representative for Irvine, California-based Edwards Lifesciences
didn’t return a phone call or e-mail seeking comment.

Perrigo Possibility

Another possibility would be to go up against Mylan in the
pursuit of Perrigo. Abbott would be a better acquirer of the $30
billion company, Kyle Bass, founder of Hayman Capital
Management, said at the SkyBridge Alternatives Conference in Las
Vegas on Thursday. Abbott is one of the few large pharmaceutical
companies that doesn’t have name-brand products that would
compete with Perrigo’s store labels, Jefferies Group said last
year.
Abbott’s acquisition strategy isn’t a matter of intent, but
of timing, CEO White said in April. Market valuations and
targets’ willingness to engage on a deal come into play, he
said.
Whatever its next target, Abbott should make the most of
the surge in Mylan shares and cash in its stake, said Vancavage
of Eagle Asset, which oversees about $32 billion.
“They said from the beginning that they weren’t going to
be long-term shareholders in Mylan and with this type of
opportunity, it’s kind of hard to pass up,” the investor said
by phone. “You don’t want to be left holding the bag.”

Buyback Option

If Abbott can’t find an acquisition, it will likely make a
large share repurchase, said Palmer of Bloomberg Intelligence.
Sitting on the cash isn’t an option.
“The cash pile will just get so big that the optics of it
would be a negative in investors’ eyes if they don’t do
something with it,” he said in a phone interview. “The CEO has
been very vocal about wanting to do deals. They already did the
big spin here with AbbVie so I think his track record speaks to
being pretty willing to pull the trigger.”

For Related News and Information:
Mylan’s Three-Way Deal Dance Is a Win for Shareholders: Real M&A
Mylan Deal Is Abbott’s Gain as Drugmaker’s Stake Grows and Grows
Abbott’s Asset Sale Provides Ammunition for Perrigo: Real M&A
Bass Recommends Perrigo, Says Abbott Better Acquirer Than Mylan
Top deal news: DTOP <GO>
Real M&A columns: NI REALMNA <GO>

To contact the reporters on this story:
Brooke Sutherland in New York at +1-212-617-0448 or
bsutherland7@bloomberg.net;
Michelle Fay Cortez in Minneapolis at +1-612-991-8887 or
mcortez@bloomberg.net
To contact the editors responsible for this story:
Beth Williams at +1-212-617-2307 or
bewilliams@bloomberg.net;
Crayton Harrison at +1-212-617-6145 or
tharrison5@bloomberg.net
Elizabeth Wollman

>>> US Close Dow+0,46% S&P+0,38% Nasdaq+0,53% Russell+0,51%


Closing Market Summary: Stocks Snap Two-Day Skid

The stock market snapped its two-day skid with a Thursday advance that lifted the S&P 500 (+0.4%) into the neighborhood of its 50-day moving average (2,089). The benchmark index narrowed its week-to-date loss to 1.0% while the Nasdaq Composite (+0.5%) outperformed, but remains down 1.2% for the week.

Equity indices vacillated near their flat lines during the opening hour and followed their shaky start with a broad-based rally. However, the cash market masked the fact that S&P 500 futures were down more than 15 points overnight. That weakness coincided with selling in the Treasury market, which abated once the benchmark 10-yr yield kissed the 2.30% level. To be fair, the overnight selloff in Treasuries did not take place in a vacuum as Germany's 10-yr bund endured a sharp plunge that briefly sent its yield as high as 0.79%. German bunds were able to retrace the entire move, returning to 0.59% while U.S. Treasuries did that and then some. The 10-yr note rallied throughout the session, dropping its yield six basis points to 2.18% and back below the 200-day moving average (2.19%).

In all likelihood, the Treasury market will be in focus once again tomorrow once the Nonfarm Payrolls report for April crosses the wires at 8:30 ET (consensus 218K).

Nine sectors finished the day in positive territory with heavily-weighted sectors like technology (+0.7%), financials (+0.7%), industrials (+0.6%), and health care (+0.5%) driving the advance.

The top-weighted technology sector gathered strength throughout the session while high-beta chipmakers outperformed from the get-go. The PHLX Semiconductor Index advanced 1.1% thanks to gains in about 90% of its components. SunEdison (SUNE 27.96, +3.13) and Atmel (ATML 7.96, +0.42) led the charge after reporting their quarterly results. Atmel jumped 5.6% after reporting a bottom line beat and issuing cautious guidance while SunEdison surged 12.6% following a loss that was not comparable to analyst estimates.

Staying in the technology space, Yelp (YELP 47.01, +8.79) spiked 23.0% after the Wall Street Journal reported the company is looking into a potential sale. The intraday spike helped the stock reclaim the bulk of its earnings-driven loss from late April and return above its 50-day moving average (46.80).

Elsewhere, the financial sector was underpinned by large components like Citigroup (C 53.31, +0.54) and JPMorgan Chase (JPM 64.50, +0.58) with their strength lifting the sector back into the green for the week. The growth-sensitive group will enter the Friday session with a week-to-date gain of 0.2%.

Over on the countercyclical side, the health care sector (+0.5%) finished ahead of its
defensively-oriented
peers thanks to strength in biotechnology. The
iShares Nasdaq Biotechnology ETF (IBB 344.11, +3.39) advanced 1.0%, but could not climb above its opening high.

On the downside, the energy sector (-1.1%) spent the day in negative territory as crude oil struggled amid dollar strength. WTI crude slumped 3.2% to $58.98/bbl while the Dollar Index (94.60, +0.51) gained 0.6%.

Today's participation was in-line with recent averages as more than 785 million shares changed hands at the NYSE floor.

Economic data included Initial Claims, Challenger Job Cuts, and Consumer Credit:
  • The initial claims level increased to 265,000 for the week ending May 2 from an unrevised 262,000 for the week ending April 25 while the consensus expected an increase to 280,000 
    • There is no doubt that businesses have actively cut down on their layoff activity. The four-week moving average for initial claims declined to 279,500 from 283,750. For comparison, it was only a little more than a month ago in March wherein the four-week moving average was stable over 300,000 
    • In the entire history of the data set, the four-week moving average has been below 280,000 only a handful of times. The last time was in May 2000 
  • The April Challenger Job Cuts report indicated that planned layoffs increased 52.8% year-over-year to follow the prior 6.4% increase 
  • Total outstanding consumer credit increased by $20.50 billion in March after increasing a downwardly revised $14.80 billion (from $15.50 billion) in February while the consensus expected an increase of $16.00 billion 
    • That was the biggest increase in consumer credit since a gain of $21.50 billion in July 2014 
Tomorrow, the Nonfarm payrolls report for April (consensus 218K) will be released at 8:30 ET while March Wholesale Inventories will be reported at 10:00 ET (consensus 0.3%).
  • Nasdaq Composite +4.4% YTD 
  • Russell 2000 +1.7% YTD 
  • S&P 500 +1.4% YTD 
  • Dow Jones Industrial Average +0.6% YTD

(BFW) Bass’s Hayman Said to Go Long on Perrigo: Business Insider




Bass’s Hayman Said to Go Long on Perrigo: Business Insider
2015-05-07 15:25:46.90 GMT


By Elizabeth Kiesche
(Bloomberg) -- Perrigo said to be Hayman Capital’s second-
largest equity position, Business Insider says.
Link

Link to Company News:{PRGO US <Equity> CN <GO>}
Link to Company News:{3832572Z US <Equity> CN <GO>}

For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}

To contact the editor responsible for this story:
Elizabeth Kiesche at +1-609-279-3116 or
ekiesche@bloomberg.net